3billion was selected as a business operator for the national project
- News | 22. 05. 18
3billion plans to form a consortium with Seoul National University Hospital and Kakao Healthcare to develop an AI integrated software solution for multifaceted analysis of rare diseases in nine groups for three years from 2022 to 2024. 3billion will be in charge of developing WGS (Whole Genome Sequencing)-based diagnostic AI models and SW solutions.
The hospitals in charge of R&D are 5 hospitals, including Seoul National University Hospital and Samsung Seoul Hospital. The SW to be developed will be verified in 13 hospitals, including 8 clinical verification network hospitals.
Original Article: Medigate News. 쓰리빌리언, 소아희귀질환 인공지능 SW 솔루션 개발 사업자 선정
Do you find this post helpful?
Click the button below to copy and share the link.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
